February 11, 2009
Its Official: KRAS Testing Needed Before Anti-EGFR Therapy
ADVERTISEMENTS
Two leading cancer organizations have concluded that for people with metastatic colon cancer, testing for what is known as the KRAS mutation before beginning anti-epidermal growth factor receptor (EGFR) therapy…
Source: About Colon Cancer
Spread the word
Leave a Comment